United States· US:50090-3472_5e9c2adc-02b6-452b-8c25-12cdaf989152
JANUVIA
A sitagliptin product containing sitagliptin phosphate, registered in United States by A-S Medication Solutions. The same ATC class is registered in 19 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Sitagliptin is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Sitagliptin · ATC A10BH01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sitagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sitagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.47
- IT Italy$1.78
- ES Spain$1.08
- FR France$0.65
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SITAGLIPTIN PHOSPHATE
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- A10BH01
- ATC class
- Sitagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150090-3472-0
- ndc1150090-3472-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for sitagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sitagliptin · interactions on record
341 records
- 3 severe
- 292 moderate
- 44 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sitagliptin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANSIFORAVipharm S.A., Ożarów Mazowiecki
- SpainALTUXERIN 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGBexal Farmaceutica S.A.
- NetherlandsAdimuplan 50 mg, filmomhulde tablettenSandoz B.V.
- PolandAdimuplanSandoz GmbH
- SwedenAxavel 50 mg Filmdragerad tablettGenepharm S.A.
- FinlandFineriaMedical Pharmaquality SA
- BelgiumJanumet 50 mg - 1000 mgMerck Sharp & Dohme
- ItalyADAGLIPADAMED S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Jansitin, Jazeta
- Belgium · Sitagliptin Eg, Sitagliptin Grindeks
- Bulgaria · Sitagliptin Grindeks, Майсиглу
- Cyprus · Jidinum, Jimandin
- Czechia · Anau, Ansifora
- Germany · Frekidir, Jansitin
- Denmark · Frekidir, Meliglix
- Estonia · Adimuplan, Maysiglu
- Spain · Altuxerin, Disit
- Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
- France · Sitagliptine Adamed, Sitagliptine Almus
- United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
- Greece · Adimuplan, Axavel
- Croatia · Adimuplan, Condias
- Hungary · Ansifora, Jaglix
- Ireland · Sitagliptin Grindeks, Sitagliptin Krka
- Iceland · Januvia, Ristaben
- Italy · Adaglip, Andamane
- Liechtenstein · Januvia, Ristaben
- Lithuania · Adimuplan, Jimandin
- Luxembourg · Sitagliptin Eg
- Latvia · Adimuplan, Jimandin
- Malta · Anau, Jidinum
- Netherlands · Adimuplan, Anau
- Norway · Frekidir, Januvia
- Poland · Ansifora, Jansitin
- Portugal · Itam, Jidinum
- Romania · Adimuplan, Jansitin
- Sweden · Axavel, Frekidir
- Slovenia · Adimuplan, Maysiglu
- Slovakia · Adimuplan, Anau
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e43c52cf-7537-4aa5-a463-e966db89303b GET /v1/drugs/e43c52cf-7537-4aa5-a463-e966db89303b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "SITAGLIPTIN PHOSPHATE",
"productndc": "50090-3472",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA021995",
"marketing_category": "NDA"
}See everything about sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.